287
36 years after discovery. Curr Gastroenterol Rep. 2014 Jan;16(1):365.
3.
Hourioux C, Sureau C, Poisson F, Brand D, Goudeau A, Roingeard P. Interaction
between hepatitis delta virus-encoded proteins and hepatitis B virus envelope
protein domains. J Gen Virol 1998; 79 ( Pt 5): 1115-1119
4.
Williams V, Brichler S, Radjef N, et al. Hepatitis delta virus proteins repress hepatitis
B virus enhancers and activate the alpha/beta interferon-inducible MxA gene. J
Gen Virol 2009; 90: 2759–67.
5.
Taylor J, Farci P, Purcell RH. Hepatitis D (Delta) virus. In: Knipe DM, Howley PM,
eds. Field’s Virology. 5th ed. Philadelphia, PA: Lippincott, Williams and Wilkins;
2006:3031–3046
6.
Purcell RH, Satterfield WC, Bergmann KF, Smedile A, Ponzetto A, Gerin JL.
Experimental hepatitis delta virus infection in the chimpanzee. Prog Clin Biol Res
1987;234:27–36
7.
Purcell RH, Satterfield WC, Bergmann KF, Smedile A, Ponzetto A, Gerin JL.
Experimental hepatitis delta virus infection in the chimpanzee. Prog Clin Biol Res
1987;234:27–36
8.
Kiesslich D, Crispim MA, Santos C, Ferreira Fde L, Fraiji NA, Komninakis SV, Diaz
RS. Influence of hepatitis B virus (HBV) genotype on the clinical course of disease
in patients coinfected with HBV and hepatitis delta virus. J Infect Dis 2009; 199:
1608-1611.
9.
18 Caredda F, Antinori S, Re T et al. Course and prognosis of acute HDV patients.
Prog Clin Biol Res 1987; 364: 267–276
10.
Deterding K, Raupach R, Cornberg M, Manns MP, Wedemeyer H: Long-term
outcome of hepatitis delta: A 14-year single center experience. Hepatology 2009;
50: 737A.
11.
Smedile A, Dentico P, Zanetti A, et al. Infectionwith the delta agent in chronic
HBsAg carriers. Gastroenterology 1981;81(6):992–997
12.
Ottobrelli A, Marzano A, Smedile A, et al. Patterns of hepatitis delta virus reinfection
and disease in liver transplantation. Gastroenterology 1991;101(6):1649–1655
13.
Yurdaydýn C, Idilman R, Bozkaya H, Bozdayi AM. Natural history and treatment of
chronic delta hepatitis. J Viral Hepat. 2010 Nov;17(11):749-56.
14.
Saracco G, Macagno S, Rosina F, RizzettoM. Serologicmarkers with fulminant
hepatitis in persons positive for hepatitis B surface antigen. A worldwide
epidemiologic and clinical survey. Ann Intern Med 1988;108(3):380–383
15.
Niro GA, Smedile A, Ippolito AM, et al. Outcome of chronic delta hepatitis in Italy: A
long-term cohort study. J Hepatol 2010; 53:834-40.
16.
Fattovich G, Giustina G, Christensen E, et al. Influence of hepatitis delta virus
infection on morbidity and mortality in compensated cirrhosis type B. The
European Concerted Action on Viral Hepatitis (Eurohep). Gut 2000; 46:420-6.
17.
Zachou K, Yurdaydin C, Drebber U, et al; HIDT-1 Study Group. Quantitative HBsAg
and HDV-RNA levels in chronic delta hepatitis. Liver Int 2010;30(3):430–437
18.
Zachou K, Yurdaydin C, Drebber U, et al, for the HIDT-1 Study Group. Quantitative
HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver Int 2010; 30: 430–37.
19.
Farci P, Gerin JL, Aragona M, et al. Diagnostic and prognostic significance of the
IgM antibody to the hepatitis delta virus. JAMA 1986;255(11):1443–1446
20.
Borghesio E, Rosina F, Smedile A, et al. Serum immunoglobulin M antibody to
hepatitis D as a surrogate marker of hepatitis D in interferon-treated patients and
in patients who underwent liver transplantation. Hepatology 1998;27(3):873–876
21.
Philipp T, Durazzo M, Trautwein C, et al. Recognition of uridine diphosphate
HDV Enfeksiyonu: Klinik
